Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Yashiro, Masakazu ^a   Hirakawa, Kosei ^a   Boland, C Richard ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN BAX; PROTEIN MSH3; PROTEIN MSH6; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; BAX PROTEIN, HUMAN; DNA BINDING PROTEIN; FAS PROTEIN, HUMAN; G T MISMATCH BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MSH3 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; SEQUENCE ANALYSIS; TUMOR GROWTH; CELL STRAIN HCT116; CELL STRAIN HT29; COLORECTAL TUMOR; COMPARATIVE STUDY; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ANTIGENS, CD95; BCL-2-ASSOCIATED X PROTEIN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; MICROSATELLITE INSTABILITY; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, IGF TYPE 2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 77953631564     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-303     Document Type: Article

References (29)

1. Boland CR. The molecular biology of gastrointestinal cancer: implications for diagnosis and therapy. Gastrointestinal endoscopy clinics of North America 2008, 18(3):401-413. vii, 10.1016/j.giec.2008.03.003, 2561895, 18674693.
2. Arnold CN, Goel A, Blum HE, Boland CR. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 2005, 104(10):2035-2047. 10.1002/cncr.21462, 16206296.
3. Yamamoto H, Gil J, Schwartz S, Perucho M. Frameshift mutations in Fas, Apaf-1, and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype. Cell death and differentiation 2000, 7(2):238-239. 10.1038/sj.cdd.4400651, 10819600.
4. Pedroni M, Sala E, Scarselli A, Borghi F, Menigatti M, Benatti P, Percesepe A, Rossi G, Foroni M, Losi L, et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer research 2001, 61(3):896-899.
5. Kambara T, Matsubara N, Nakagawa H, Notohara K, Nagasaka T, Yoshino T, Isozaki H, Sharp GB, Shimizu K, Jass J, et al. High frequency of low-level microsatellite instability in early colorectal cancer. Cancer research 2001, 61(21):7743-7746.
6. Drewinko B, Romsdahl MM, Yang LY, Ahearn MJ, Trujillo JM. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer research 1976, 36(2 Pt 1):467-475.
7. Dexter DL, Barbosa JA, Calabresi P. N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer research 1979, 39(3):1020-1025.
8. Leibovitz A, Stinson JC, McCombs WB, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer research 1976, 36(12):4562-4569.
9. Tom BH, Rutzky LP, Jakstys MM, Oyasu R, Kaye CI, Kahan BD. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In vitro 1976, 12(3):180-191. 10.1007/BF02796440, 1262041.
10. Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer research 1981, 41(5):1751-1756.
11. Chen TR, Drabkowski D, Hay RJ, Macy M, Peterson W. WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. Cancer genetics and cytogenetics 1987, 27(1):125-134. 10.1016/0165-4608(87)90267-6, 3472642.
12. Jass JR, Sobin LH, Watanabe H. The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer 1990, 66(10):2162-2167. 10.1002/1097-0142(19901115)66:10<2162::AID-CNCR2820661020>3.0.CO;2-N, 2171747.
13. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part II. Histopathological classification. Japanese Research Society for Cancer of the Colon and Rectum. Jpn J Surg 1983, 13(6):574-598. 10.1007/BF02469506, 6672391.
14. Yashiro M, Carethers JM, Laghi L, Saito K, Slezak P, Jaramillo E, Rubio C, Koizumi K, Hirakawa K, Boland CR. Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer research 2001, 61(6):2676-2683.
15. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer research 1998, 58(22):5248-5257.
16. Carethers JM, Pham TT. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines. In Vivo 2000, 14(1):13-20.
17. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clinical genetics 2009, 76(1):1-18. 10.1111/j.1399-0004.2009.01230.x, 2846640, 19659756.
18. Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 2008, 29(4):673-680. 10.1093/carcin/bgm228, 17942460.
19. Akiyama Y, Yagi OK, Ishikawa T, Nagasaki H, Saitoh K, Yuasa Y. Genetic alterations are frequent in APC but rare in the TGF-beta type II receptor gene in cancer in adenomas of the colon. Cancer Lett 1998, 125(1-2):89-96. 10.1016/S0304-3835(97)00490-4, 9566701.
20. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, Kishi N, Iwama T, Mori T, Koike M, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 1996, 111(2):307-317. 10.1053/gast.1996.v111.pm8690195, 8690195.
21. Grady WM, Rajput A, Myeroff L, Liu DF, Kwon K, Willis J, Markowitz S. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer research 1998, 58(14):3101-3104.
22. Shin KH, Park YJ, Park JG. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. Clin Cancer Res 2000, 6(2):536-540.
23. Ogata S, Tamura G, Endoh Y, Sakata K, Ohmura K, Motoyama T. Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer. J Pathol 2001, 194(3):334-340. 10.1002/path.895, 11439366.
24. Pinto M, Oliveira C, Cirnes L, Carlos Machado J, Ramires M, Nogueira A, Carneiro F, Seruca R. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas. J Pathol 2003, 200(1):32-38. 10.1002/path.1327, 12692838.
25. Munoz NM, Upton M, Rojas A, Washington MK, Lin L, Chytil A, Sozmen EG, Madison BB, Pozzi A, Moon RT, et al. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer research 2006, 66(20):9837-9844. 10.1158/0008-5472.CAN-06-0890, 17047044.
26. Alazzouzi H, Davalos V, Kokko A, Domingo E, Woerner SM, Wilson AJ, Konrad L, Laiho P, Espin E, Armengol M, et al. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. Cancer research 2005, 65(22):10170-10173. 10.1158/0008-5472.CAN-05-2580, 16288001.
27. Woerner SM, Benner A, Sutter C, Schiller M, Yuan YP, Keller G, Bork P, Doeberitz MK, Gebert JF. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes. Oncogene 2003, 22(15):2226-2235. 10.1038/sj.onc.1206421, 12700659.
28. Korff S, Woerner SM, Yuan YP, Bork P, von Knebel Doeberitz M, Gebert J. Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability. BMC cancer 2008, 8:329. 10.1186/1471-2407-8-329, 2586028, 19000305.
29. Kim JJ, Baek MJ, Kim L, Kim NG, Lee YC, Song SY, Noh SH, Kim H. Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability. Lab Invest 1999, 79(9):1113-1120.